The scientist’s investigation covers issues in Dopamine receptor D2, Adenosine, Receptor, Neuroscience and Adenosine A2A receptor. His Dopamine receptor D2 research integrates issues from G protein-coupled receptor and Cell biology. Sergi Ferré combines subjects such as Adenosine A1 receptor, Adenosine receptor, Caffeine, Dopamine receptor and Colocalization with his study of Adenosine.
In general Receptor, his work in Dopamine receptor D1 and Heteromer is often linked to Information exchange and Research questions linking many areas of study. In his research, Neurotransmission and Adenosine receptor antagonist is intimately related to Glutamatergic, which falls under the overarching field of Neuroscience. His Adenosine A2A receptor research focuses on Purinergic signalling and how it connects with Metabotropic glutamate receptor.
Sergi Ferré spends much of his time researching Receptor, Dopamine receptor D2, Neuroscience, Endocrinology and Internal medicine. Sergi Ferré has researched Receptor in several fields, including Biophysics, Cooperativity and Cell biology. His Dopamine receptor D2 research incorporates elements of Dopamine receptor, Adenosine A2B receptor, Adenosine A2A receptor and Adenosine.
His Adenosine study incorporates themes from Adenosinergic, Purinergic signalling, Caffeine and Pharmacology. Sergi Ferré studies Neuroscience, focusing on Dopamine in particular. The various areas that Sergi Ferré examines in his Endocrinology study include Agonist, Adenosine A1 receptor, Adenosine receptor and Receptor antagonist.
Sergi Ferré mostly deals with Neuroscience, Dopamine, Receptor, Adenosine and Adenosine A2A receptor. His Neuroscience research incorporates themes from Glutamatergic, Heteromer and Huntington's disease. His Dopamine study combines topics in areas such as Stimulation and Caffeine.
His Receptor study combines topics from a wide range of disciplines, such as Luciferase and Pharmacology. His Adenosine study results in a more complete grasp of Internal medicine. His biological study spans a wide range of topics, including Cancer research, Dopamine receptor D2, Disease and Cell biology.
His primary areas of investigation include Dopamine, Neuroscience, Dopamine receptor D2, Adenosine A2A receptor and Heteromer. Internal medicine and Endocrinology are inherently bound to his Dopamine studies. He mostly deals with Receptor in his studies of Internal medicine.
His Dopamine receptor D2 study frequently draws connections between related disciplines such as Pharmacology. His Adenosine A2A receptor research is multidisciplinary, incorporating elements of Adenylyl cyclase, G protein and Cell biology. His Heteromer study integrates concerns from other disciplines, such as Intrinsic activity, Adenosine and Allosteric regulation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Sergi Ferré;Kjell Fuxe;Bertil B. Fredholm;Micaela Morelli.
Trends in Neurosciences (1997)
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
S Ferre;G von Euler;B Johansson;B B Fredholm.
Proceedings of the National Academy of Sciences of the United States of America (1991)
Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1–A2A Receptor Heteromers
Francisco Ciruela;Vicent Casadó;Ricardo J. Rodrigues;Rafael Luján.
The Journal of Neuroscience (2006)
Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors
Joëlle A. Hillion;Meritxell Canals;Maria Torvinen;Vicent Casado.
Journal of Biological Chemistry (2002)
Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization QUALITATIVE AND QUANTITATIVE ASSESSMENT BY FLUORESCENCE AND BIOLUMINESCENCE ENERGY TRANSFER
Meritxell Canals;Daniel Marcellino;Francesca Fanelli;Francisco Ciruela.
Journal of Biological Chemistry (2003)
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes
Silvia Ginés;Joëlle Hillion;Maria Torvinen;Stèphane Le Crom.
Proceedings of the National Academy of Sciences of the United States of America (2000)
G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Sergi Ferré;Vicent Casadó;Lakshmi A. Devi;Marta Filizola.
Pharmacological Reviews (2014)
An update on the mechanisms of the psychostimulant effects of caffeine
Sergi Ferré.
Journal of Neurochemistry (2008)
Adenosine-dopamine interactions in the brain
S. Ferré;K. Fuxe;G. von Euler;B. Johansson.
Neuroscience (1992)
Building a new conceptual framework for receptor heteromers
Sergi Ferré;Ruben Baler;Michel Bouvier;Marc G. Caron.
Nature Chemical Biology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Barcelona
Karolinska Institute
University of Barcelona
University of Barcelona
University of Barcelona
University of Barcelona
National Institute on Drug Abuse
University of Barcelona
National Institute on Drug Abuse
Karolinska Institute
University of Maryland, College Park
University of Queensland
Polish Academy of Sciences
Polytechnique Montréal
Colorado State University
Agricultural Research Service
Fibrocor Therapeutics
Universidade de São Paulo
California Institute of Technology
University of Sheffield
Vrije Universiteit Brussel
University of Erlangen-Nuremberg
Maastricht University
Johns Hopkins University
Columbia University
Apache Corporation